About Index Trending news
Analyze
Top 50 Pricing
Pluristem

Pluristem

Work at Pluristem? Add yourself to this profile

Pluristem

A bio-therapeutics company developing a pipeline of products derived from human placenta - a non-controversial adult stem cell source.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

25 Oct 2016
$30,000,000
Post-IPO equity
Innovative Medical Management